TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/06/2026
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Quick snapshot
TARGINTA
ST13
US500000079309367Class
Filing
Registration
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Holders
Representatives
Julie A. Greenberg Reising Ethington P.C.
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparations for use in industry and science; stem cells for research or scientific purposes; antibodies for research and industrial purposes, namely, Biochemicals in the nature of monoclonal antibodies for in vitro scientific or research use, Laboratory chemicals in the nature of an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use, Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; DNA and RNA for scientific and industrial purposes, namely, Test particles for biodetection systems, biological analogues and microscopic carrier beads with chemically attached DNA fragments for use in testing the operation of equipment used for analyzing air for the presence of harmful biological substances, Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields, Reagent kit comprising enzyme and chemicals for in vitro transcription of RNA and modified RNA, Gene-based RNA molecular network biomarker reagents for research purposes; proteins for use in science being protein in raw material form for scientific research; chemical test kits, consisting of stem cells, antibodies and proteins, for scientific and industrial purposes for laboratory or research use; reagents for scientific purposes; diagnostic reagents for scientific purposes, not for medical or veterinary purposes; analytical preparations being Chemical buffer and standard solutions used in analytical chemistry, Reagents used for analytical moisture determinations, Reagents for use in scientific apparatus for chemical or biological analysis, Laboratory chemicals in the nature of an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use, Chemical substances for analyses in laboratories, other than for medical or veterinary purposes for scientific purposes related to cancer treatment and therapies
Class 5
Pharmaceutical and veterinary preparations for the treatment of cancer and for cancer therapies used in the treatment of cancer; stem cells for medical purposes; stem cells for medical and veterinary use; DNA and RNA for medical and veterinary purposes, namely, gene-based RNA molecular network biomarker reagents for medical diagnosis purposes, Medical therapeutic preparations in the nature of biologically active antisense DNA or RNA compounds, Biological products for medical use in recombinant DNA technology in the nature of DNA products allowing recombinant production of polypeptides and monoclonal antibodies; surgical implants grown from stem cells comprising living tissues; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; biological preparations for the treatment of cancer for medical and veterinary purposes; diagnostic kit consisting of stem cells, monoclonal antibodies and proteins for use in disease testing for medical and veterinary purposes; Reagents for medical use, namely, reagents for medical diagnosis and analysis; diagnostic preparations for medical and veterinary use
Class 42
Scientific research; laboratory testing services, namely, scientific research, diagnosis, testing and analysis in the fields of medicine, chemistry, stem cells, RNA, DNA, antibodies and proteins; basic and clinical research in the field of respiratory science and medicine, in particular in relation to the development of medicines; research and development services in the field of diagnostic preparations; quality control for others
History of USPTO decisions and trademark events.
33 publications found
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/06/2026
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/06/2026
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/06/2026
FINAL DECISION TRANSACTION PROCESSED BY IB
11/07/2022
FINAL DISPOSITION NOTICE SENT TO IB
10/19/2022
FINAL DISPOSITION PROCESSED
10/19/2022
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/12/2022
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/12/2022
REGISTERED-PRINCIPAL REGISTER
07/12/2022
NOTIFICATION PROCESSED BY IB
05/03/2022
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/26/2022
PUBLISHED FOR OPPOSITION
04/26/2022
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/13/2022
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/13/2022
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2022
APPROVED FOR PUB - PRINCIPAL REGISTER
03/24/2022
EXAMINER'S AMENDMENT ENTERED
03/24/2022
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/24/2022
EXAMINERS AMENDMENT E-MAILED
03/24/2022
EXAMINERS AMENDMENT -WRITTEN
03/24/2022
TEAS/EMAIL CORRESPONDENCE ENTERED
03/16/2022
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2022
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/15/2022
ASSIGNED TO EXAMINER
03/09/2022
REFUSAL PROCESSED BY IB
10/25/2021
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/27/2021
REFUSAL PROCESSED BY MPU
09/27/2021
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/10/2021
NON-FINAL ACTION WRITTEN
09/09/2021
ASSIGNED TO EXAMINER
08/27/2021
APPLICATION FILING RECEIPT MAILED
04/27/2021
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/23/2021
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/22/2021
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.